Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ALLO — Allogene Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$533,686
+$316,087 QoQ
Shares Held
256,580
+187.7% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ALLO ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ALLO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $533,686 256,580
2026-03-31 $217,599 89,180
2025-12-31 $274,378 200,276
2025-09-30 $179,627 144,861
2025-06-30 $144,132 127,551
2025-03-31 $156,653 107,297
2024-12-31 $222,782 104,593
2024-09-30 $226,279 80,814
2024-06-30 $158,108 67,858
2024-03-31 $246,761 55,204
2023-12-31 $173,884 54,170
2023-09-30 $535,622 168,966
2023-06-30 $823,911 165,777
2023-03-31 $652,213 132,027
2022-12-31 $33,462 5,320
2022-09-30 $77,704 7,195
2022-06-30 $79,719 6,993
2022-03-31 $120,378 13,214
2021-12-31 $580,253 38,891
2021-09-30 $525,178 20,435
2021-06-30 $281,403 10,790
2021-03-31 $187,866 5,322
2020-12-31 $882,919 34,981
2020-09-30 $1,098,378 29,127
2020-06-30 $874,896 20,432
2020-03-31 $557,868 28,697